biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
Category
Uncategorized
13
Jan
Scope Fluidics has commenced the verification of the BacterOMIC system, which is one of the elements of the preregistration procedure
13.01.2021
Mateusz
Uncategorized
Read More
15
Feb
Scope Fluids has finished preregistration tests on the SARS Cov-2 panel
15.02.2021
Mateusz
Uncategorized
Read More
16
Feb
Scope Fluidics has begun the certification tests on the MRSA panel
16.02.2021
Mateusz
Uncategorized
Read More
02
Apr
Scope Fluidics completes clinical trials of a rapid PCR|ONE genetic test for detecting Staphylococcus aureus and its drug-resistant variants (MRSA)
02.04.2021
Mateusz
Uncategorized
Read More
15
Apr
PCR|ONE System receives European CE-IVD certificate for its MRSA/MSSA panel Early Access Program to start in Q3/2021
15.04.2021
Mateusz
Uncategorized
Read More
19
Apr
Another SPV of Scope Fluidics with positive recommendation regarding ISO 13485:2016 compliance certification
19.04.2021
Mateusz
Uncategorized
Read More
11
May
Scope Fluidics closer to obtain financing from the EIB
11.05.2021
Mateusz
Uncategorized
Read More
10
Jun
Scope Fluidics launches clinical trials of the BacterOMIC system in second external laboratory
10.06.2021
Mateusz
Uncategorized
Read More
30
Jun
Scope Fluidics: completion of clinical trials for SARS-CoV-2 panel
30.06.2021
Mateusz
Uncategorized
Read More
03
Aug
Scope Fluidics Group’s SPV enters into cooperation with Technicolor Precision BioDevices (Technicolor Poland)
03.08.2021
Mateusz
Uncategorized
Read More
1
…
7
8
9
10
11
…
13
Search
Text Widget
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments
Tag Cloud
home
Recent Comments